Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • News
    Fortis board decides to consider only Binding Offers, Faces BacklashFortis board decides to consider only Binding Offers, Faces Backlash
    Cognizant completes acquisition of Bolder Healthcare SolutionsCognizant completes acquisition of Bolder Healthcare Solutions
    Top Indian Pharma formulators eyeing OTC market: ReportTop Indian Pharma formulators eyeing OTC market: Report
    NABL working towards calibration of medical equipmentsNABL working towards calibration of medical equipments
    WHO recommends testing before use of Sanofis dengue vaccineWHO recommends testing before use of Sanofi's dengue vaccine
    Fortis Update: Munjals, Burmans better their offer, BLK promoter likely to bidFortis Update: Munjals, Burmans better their offer, BLK promoter likely to bid
    Lupin gets tentative USFDA nod to market testosterone gelLupin gets tentative USFDA nod to market testosterone gel
    Doctors, medical professionals highest paid in India: ReportDoctors, medical professionals highest paid in India: Report
    Another Suitor in Line for Fortis, this time a Chinese ConglomerateAnother Suitor in Line for Fortis, this time a Chinese Conglomerate
    Maximum 24 percent Margin on Scheduled drugs, 30 on Non scheduled: NITI AayogMaximum 24 percent Margin on Scheduled drugs, 30 on Non scheduled: NITI Aayog
    Govt to define stem cells as DRUG, regulate use in therapyGovt to define stem cells as DRUG, regulate use in therapy
    Mosquitoes, gnats in Plant; no quality control: USFDA investigators Observe on Alkem PlantMosquitoes, gnats in Plant; no quality control: USFDA investigators Observe on Alkem Plant
    PrevNext

    Popular Stories

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    Ayurvedic Medicines for Blood Sugar, Diet containing Metformin Hydrochloride: Ayurveda Firm Booked

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    FDC Ban: Supreme Court Relief to Saridon, Piriton and Dart

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    CDSCO bans OTC sale of topical medications containing hydroquinone from April 1, 2019

    FDC Ban: Avoid These Combinations of Paracetamol

    FDC Ban: Avoid These Combinations of Paracetamol

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop production

    Rising prices of hydroxychloroquine raw material forces small scale pharmas in Haridwar to stop...

    Health Minsitry bans 328 FDC Banned Drugs, check out the complete list

    Health Minsitry bans 328 FDC Banned Drugs, check out the complete list

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Illegal steroid smuggling ring allegedly led by India-based Alpha Pharma busted in UK

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    Ayurvedic drugs- Power up capsules, Tiger king cream found laced with Viagra, Anaesthetic: FDA

    View All

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok